Regarding the problem of viral hepatitis reactivation in rheumatic diseases: risks and curation issues-Reference-Cited by-同舟云学术

Regarding the problem of viral hepatitis reactivation in rheumatic diseases: risks and curation issues

Published:2020-12-10 Issue:19 Volume: Page:98-106
ISSN:2658-5790
Container-title:Meditsinskiy sovet = Medical Council
language:
Short-container-title:Medicinskij sovet

Author:

Belov B. S.¹^ORCID,Muravyeva N. V.¹^ORCID,Tarasova G. M.¹^ORCID

Affiliation:

1. Nasonova Research Institute of Rheumatology

Publisher

Remedium, Ltd.

Subject

General Medicine

Reference75 articles.

1. Polaris Observatory Collaborators. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol. 2018;3(6):383-403. doi: 10.1016/S2468-1253(18)30056-6.

2. European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017;67(2):370-398. doi: 10.1016/j.jhep.2017.03.021.

3. Shapiyeva N.T., Ponezheva Zh.B., Makashova V.V., Omarova Kh. G. Modern aspects of chronic hepatitis B. Lechashchiy vrach. 2019;(5). (In Russ.) Available at: https://www.lvrach.ru/2019/05/15437301.

4. Charpin C., Guis S., Colson P., Borentain P., Mattei J.P., Alcaraz P et al. Safety of TNF-blocking agents in rheumatic patients with serology suggesting past hepatitis B state: results from a cohort of 21 patients. Arthritis Res Ther. 2009;11(6):R179. doi: 10.1186/ar2868.

5. Kato M., Atsumi T., Kurita T., Odani T., Fujieda Y., Otomo K. et al. Hepatitis B virus reactivation by immunosuppressive therapy in patients with autoimmune diseases: risk analysis in Hepatitis B surface antigen-negative cases. J Rheumatol. 2011;38(10):2209-2214. doi: 10.3899/jrheum.110289.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic viral hepatitis B and rheumatic diseases: Modern view on problem;Medical alphabet;2022-12-25